SKHX Falls Again as an Asia Chip Rout Compounds SK Hynix's HBM Earnings Warning

The Warning Behind the Rout

The 21-hour slide isn't only chip-sector beta. The proximate catalyst is a research note from Korea Investment & Securities projecting SK Hynix's Q2 operating profit roughly 8% below street consensus. The reason is counterintuitive for a company sitting at the center of the AI trade: not soft demand, but long-term HBM supply contracts that lock in pricing and cap how much SK Hynix can capture from spot memory strength. The broker trimmed its blended DRAM average-selling-price growth estimate for the quarter from around 50% to roughly 29% quarter-over-quarter, and others — Mirae Asset, Hyundai Motor Securities — followed with cuts of their own. The bull case (memory scarcity, AI-driven pricing) is intact; the near-term earnings math just got repriced.

From Record Debut to Record Crash

A week ago SK Hynix was the story. Its $26.5 billion Nasdaq ADR debut was one of the largest of the year, and the US shares popped nearly 13% above the $149 offering price on day one. The reversal since has been just as sharp: the Seoul common posted a drop of more than 15% on July 13, its worst single session on record, triggering a trading halt as the KIS note landed. The July 16 leg piled on — SK Hynix fell roughly 11% in Seoul, erasing the prior session's ~8% bounce, while Samsung Electronics dropped about 7% and US memory names (Micron, SanDisk, Western Digital each near 5%) sold off in sympathy. This is a crowded-trade unwind as much as a fundamental one: semiconductors now make up roughly 20% of the S&P 500, and positioning that heavy tends to correct hard.

The Leg This Perp Actually Prices

SKHX tracks the KRW price of one SK Hynix Seoul share converted to USD, which matters right now because the stock trades in two places at once. The Nasdaq ADR and the Seoul common have moved at different speeds through this correction, and the perp is anchored to the pressured Korean line rather than the US one. At about $1,236, SKHX sits below where last week's ADR enthusiasm implied — it is expressing the profit-taking side of the same name. The next real test is the Q2 print: if actual HBM and DRAM pricing lands closer to the pre-cut consensus than to the reduced brokerage estimates, the repricing overshot; if the contract-driven ASP caps are as binding as the brokers now model, the correction has fundamental support rather than resting on sentiment alone.